Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea L Schaffer

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
BJGP Open|November 11, 2020
Pregabalin prescribing patterns in Australian general practice, 2012-2018: a cross-sectional studyAndrea L Schaffer, Doreen Busingye, Kendal Chidwick, et al.
BMJ Supportive & Palliative Care|April 14, 2026
Electronic health record data to develop indicators of end-of-life care qualityStuti Bagri, Sophie Julian, Miranda Davies, et al.
JAMA Internal Medicine|July 6, 2016
Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug UseAndrea L Schaffer, Nicholas A Buckley, Rose Cairns, et al.
AIDS Care|March 18, 2022
Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short reportJuliana de Oliveira Costa, Yalin Zhao, Sallie-Anne Pearson, et al.
Plos One|June 15, 2022
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in AustraliaAndrea L Schaffer, David Henry, Helga Zoega, et al.
Pharmacotherapy|October 14, 2022
A nationwide study of multimedicine use in people treated with cardiovascular medicines in AustraliaAndrea L Schaffer, Joel Chia, Jonathan Brett, et al.
Addiction (Abingdon, England)|January 24, 2019
Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)-in replyRose Cairns, Andrea L Schaffer, Nicole Ryan, et al.
Addiction (Abingdon, England)|August 12, 2018
Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisoningsRose Cairns, Andrea L Schaffer, Nicole Ryan, et al.
The Medical Journal of Australia|June 13, 2015
The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?Andrea L Schaffer, Nicholas A Buckley, Timothy A Dobbins, et al.
Addiction (Abingdon, England)|October 3, 2019
Codeine use and harms in Australia: evaluating the effects of re-schedulingRose Cairns, Andrea L Schaffer, Jared A Brown, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
BJGP Open|November 11, 2020
Pregabalin prescribing patterns in Australian general practice, 2012-2018: a cross-sectional studyAndrea L Schaffer, Doreen Busingye, Kendal Chidwick, et al.
BMJ Supportive & Palliative Care|April 14, 2026
Electronic health record data to develop indicators of end-of-life care qualityStuti Bagri, Sophie Julian, Miranda Davies, et al.
JAMA Internal Medicine|July 6, 2016
Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug UseAndrea L Schaffer, Nicholas A Buckley, Rose Cairns, et al.
AIDS Care|March 18, 2022
Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short reportJuliana de Oliveira Costa, Yalin Zhao, Sallie-Anne Pearson, et al.
Plos One|June 15, 2022
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in AustraliaAndrea L Schaffer, David Henry, Helga Zoega, et al.
Pharmacotherapy|October 14, 2022
A nationwide study of multimedicine use in people treated with cardiovascular medicines in AustraliaAndrea L Schaffer, Joel Chia, Jonathan Brett, et al.
Addiction (Abingdon, England)|January 24, 2019
Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)-in replyRose Cairns, Andrea L Schaffer, Nicole Ryan, et al.
Addiction (Abingdon, England)|August 12, 2018
Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisoningsRose Cairns, Andrea L Schaffer, Nicole Ryan, et al.
The Medical Journal of Australia|June 13, 2015
The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?Andrea L Schaffer, Nicholas A Buckley, Timothy A Dobbins, et al.
Addiction (Abingdon, England)|October 3, 2019
Codeine use and harms in Australia: evaluating the effects of re-schedulingRose Cairns, Andrea L Schaffer, Jared A Brown, et al.
Pageof 8